Abstract
The genetic-environment combination is central to the genesis of obesity. Obesity emerged as one of the major health problems during the last century, from the enormous environmental changes that the world experienced. Environmental factors favoring a positive energy balance and weight gain include, on the one hand, increased availability of food, particularly high-calorie foods, and increased portion sizes and, on the other hand, decreased movement, with less time of physical activity at work and the replacement of physical activity in leisure time with sedentary activities such as watching TV and the use of electronic devices. Other factors considered to contribute to the obesity epidemic are use of drugs that have weight gain as a side effect, reduction in variability of ambient temperatures, sleep debt, increasing maternal age, greater fecundity among people with higher adiposity, assortative mating, endocrine disruptors, microorganisms, epigenetics, and intrauterine and intergenerational effects. These and many other factors, combined with medical innovations that have reduced mortality and prolonged life, laid the foundation for the obesity epidemic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Popkin BM, Hawkes C. Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses. Lancet Diabetes Endocrinol. 2016;4:174–86.
Church TS, Thomas DM, Tudor-Locke CT. Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity. PLoS One. 2011;6(5):e19657.
Mc Allister EJ, Dhurandhar N, Keith S. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49:868–913.
Allison DB, Downey M, Atkinson RL. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring). 2008;16:1161–77.
Garvey T, Mechanick JI, Brett EM. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1–203.
Wadden TA, Butryn ML, Hong PS, Wadden TA. Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review. JAMA. 2014;312:1779–91.
Antognoli EL, Seeholzer EL, Gullett H. Primary care resident training for obesity, nutrition, and physical activity counseling. Health Promot Pract. 2017;18(5):672–80.
Gudzune KA, Beach MC, Roter DL. Physicians build less rapport with obese patients. Obesity (Silver Spring). 2013;21(10):2146–52.
Jensen MD, Ryan DH, Donato KA, Apovian CM, Ard JD, Comuzzie AG, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ. Guidelines (2013) for managing overweight and obesity in adults. Obesity. 2014;22(S2):S1–S410.
National Institute for Health and Care Excellence (UK). National Institute for Health and Clinical Excellence: guidance. Obesity: identification, assessment and management of overweight and obesity in children, young people and adults: partial update of CG43. National Clinical Guideline Centre (UK). 2014.
Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring). 2014;22(1):5–13.
Bray GA, Frühbeck G, Ryan DH. Management of obesity. Lancet. 387(10031):1947–56.
Unick JL, Neiberg RH, Hogan PE. Weight change in the fi rst 2 months of a lifestyle intervention predicts weight changes 8 years later. Obesity (Silver Spring). 2015;23:1353–6.
Watson S, Woodside JV, Ware LJ. Effect of a web-based behavior change program on weight loss and cardiovascular risk factors in overweight and obese adults at high risk of developing cardiovascular disease: randomized controlled trial. J Med Internet Res. 2015;17(7):e177.
Stuart R. Behavioral control of overeating. Behav Ther. 1967;5:357–65.
Association ACoCH. Task force on Practice Guidelines, Obesity Expert Panel, 2013. Expert panel report: guidelines (2013) for the management of overweight and obesity in adults. Obesity (Silver Spring). 2014;22(Suppl 2):S41–410.
Baker RC, Kirschenbaum D. Self-monitoring may be necessary for successful weight control. Behav Ther. 1993;24(3):377–94.
Klem ML, Wing RR, MT MG. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr. 1977;66(2):239–46.
Mc Guire M, Wing RR, Klem ML. Behavioral strategies of individuals who have maintained long-term weight losses. Obes Res. 1999;7(4):334–41.
Steinberg D, Tate D, Bennett G. The efficacy of a daily self-weogjomg weight loss intervention using smart scales and e-mail. Obesity (Silver Spring). 2013;21(9):1789–97.
Knowler WC, Barrett-Connor E, Fowler SE. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
Knowler WC, Fowler SE, Hamman RF. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86.
Wadden TA, Berkowitz RI, Womble LG. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353(20):2111–21120.
Wing RR, Tate D, Gorin A. A self-regulation program for maintenance of weight loss. N Engl J Med. 2006;355(15):1563–71.
Brownell KD. The LEARN program for weight management. Dallas: American Health Publishing Company; 2004. ISBN-10: 1878513419; ISBN-13: 978-1878513410
Alamuddin N, Wadden TA. Behavioral treatment of the patient with obesity. Endocrinol Metab Clin N Am. 2016;45(3):565–80.
Kokkinos A, le Roux CW, Alexiadou K. Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1. J Clin Endocrinol Metab. 2010;95(1):333–7.
Avenell A Broom J, Brown TJ. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess. 2004;8(21):III–V.
Foreyt JP, Johnston C. Behavior modification and cognitive therapy. In: Mechanick J, editor. Lifestyle medicine a manual for clinical practice. Cham: Springer International Publishing; 2016. Chapter 14, p. 129–34.
Perri MG, Limacher MC, Durning PE. Extended-care programs for weight management in rural communities: the treatment of obesity in undeserved rural settings (TOURS) randomized trial. Arch Intern Med. 2008;168(21):2347–54.
Heymsfield SB, Wadden T. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254–66.
Ryan D, Heaner M. Guidelines (2013) for managing overweight and obesity in adults. Obesity. 2014;22(suppl 2):S1–3.
Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332(10):621–8.
Das SK, Gilhooly CH, Golden JK. Long-term effects of 2 energy-restricted diets differing in glycemic load on dietary adherence, body composition, and metabolism in CALERIE: a 1-y randomized controlled trial. Am J Clin Nutr. 2007;85(4):1023–30.
Johnston BC, Kanters S, Bandayrel K. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA. 2014;312(9):923–33.
Apovian CM, Aronne LJ, Bessesen DH. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.
Stegenga H, Haines A, Jones K, Wilding J. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ. 2014;349:g6608. https://doi.org/10.1136/bmj.g6608.
Logue J, Thompson L, Romanes F. Scottish Intercollegiate Guidelines Network. Guidelines: management of obesity: summary of SIGN guideline. BMJ. 2010;340.; 7744(27):474–7.
Tsai AG, Wadden TA. The evolution of very-low-calorie diets: an update and meta-analysis. Obesity (Silver Spring). 2006;14(8):1283–93.
Westman EC, Feinman RD, Mavropoulos JC. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007;86:276–84.
Tobias DK, Chen M, Manson JE, Ludwig DS, Willett W, Hu FB. Effect of low-fat diet in-terventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3(12):968–79.
Hall K. Prescribing low-fat diets: useless for long-term weight loss? Lancet Diabetes Endocrinol 2015; Published Online S2213-8587 (15) 00413-1.
Ludwig DS, Friedman MI. Increasing adiposity: consequence or cause of overeating? JAMA. 2014;311(21):2167–8.
Hall K, Bemis T, Brychta R. Calorie for calorie, dietary fat restriction results in more body fat loss than carbohydrate restriction in people with obesity. Cell Metab. 2015;22(3):427–36.
Hession M, Rolland C, Kulkarni U. Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obes Rev. 2009;10(1):36–50.
Franz MJ, VanWormer JJ, Crain AL. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007;107(10):1755–67.
Hall KD, Sacks G, Chandramohan D. Quantification of the effect of energy imbalance on bodyweight. Lancet. 2011;378(9793):826–37.
Sanghvi A, Redman LM, Martin CK. Validation of an inexpensive and accurate mathematical method to measure long-term changes in free-living energy intake. Am J Clin Nutr. 2015;102(2):353–8.
MacLean PS, Wing RR, Davidson T. NIH working group report: innovative research to improve maintenance of weight loss. Obesity (Silver Spring). 2015;23(1):7–15.
Sumithran P, Prendergast LA, Delbridge E. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597–604.
National Institute for Health and Clinical Excellence: Guidance. Obesity: identification, assessment and management of overweight and obesity in children, young people and adults. London: National Clinical Guideline Centre (UK). National Institute for Health and Care Excellence (UK); 2014. nice.org.uk/guidance/cg189.
Ross R, Hudson R, Stotz PJ. Effects of exercise amount and intensity on abdominal obesity and glucose tolerance in obese adults: a randomized trial. Ann Intern Med. 2015;162(5):325–34.
National Institute for Health and Clinical Excellence (NICE). Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. London: NICE; 2006. Available from url: http://guidance.nice.org.uk/CG43.
Slentz CA, Duscha BD, Johnson JL. Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE–a randomized controlled study. Arch Intern Med. 2004;164(1):31–9.
Hinkle W, Cordell M, Leibel R. Effects of reduced weight maintenance and leptin repletion on functional connectivity of the hypothalamus in obese humans. PLoS One. 2013;8:e5914.
Rosembaum M, Hirsch J, Gallagher DA. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr. 2008;88(4):906–12.
Pucci A, Finer N. New medications for treatment of obesity: metabolic and cardiovascular effects. Can J Cardiol. 2015;31(2):142–52.
Nuffer W, Trujillo JM, Megyeri JA. Comparison of new pharmacological agents for the treatment of obesity. Ann Pharmacother. 2016;50(5):376–88.
Weintraub M, Sundaresan PR, Madan M. Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise. Clin Pharmacol Ther. 1992;51(5):595–601.
Sjöström L, Rissanen A, Andersen T. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998;352(9123):167–72.
Chanoine JP, Hampl S, Jensen C. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA. 2005;293(23):2873–83.
Torgerson JS, Hauptman J, Boldrin MN. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27(1):155–61.
Smith SR, Weissman NJ, Anderson CM. Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363(3):245–56.
Fidler MC, Sanchez M, Raether B, for the BLOSSOM Clinical Trial Group. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011;96(10):3067–77.
Aronne LJ, Wadden TA, Peterson C. Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Obesity (Silver Spring). 2013;21(11):2163–71.
Allison DB, Gadde KM, Garvey WT. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2010;20(2):330–42.
Apovian CM, Aronne L, Rubino D, COR-II Study Group. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013;21(5):935–43.
Wadden TA, Foreyt JP, Foster GD. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011;19(1):110–20.
Astrup A, Carraro R, Finer N. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond). 2012;36(6):843–54.
Gadde KM, Allison DB, Ryan DH. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9774):1341–52.
Crane J, McGowan B. The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity. Ther Adv Chronic Dis. 2016;7(2):92–107.
Rueda-Clausen CF, Padwal RS, Sharma AM. New pharmacological approaches for obesity management. Nat Rev Endocrinol. 2013;9:467–78.
Giddens JM, Sheehan KH, Sheehan DV. The Columbia suicidality severity rating scale (C-SSRS): has the gold standard become a liability? Innov Clin Neurosci. 2014;11(9–10):66–80.
Khera R, Murad MH, Chandar AK. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424.
Chang SH, Stoll CR, Song J. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis 2003–2012. JAMA Surg. 2014;149(3):275–87.
Schauer PR, Bhatt DL, Kirwan JP for the STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes – 5-year outcomes. N Engl J Med. 2017;376(7):641–51.
Arterburn DE, Weidenbacher H, Maciejewski ML. Association between bariatric surgery and long-term survival. JAMA. 2015;313(1):62–70.
Wang BC, Furnback W. Modelling the long-term outcomes of bariatric surgery: a review of cost-effectiveness studies. Best Pract Res Clin Gastroenterol. 2013;27(6):987–95.
Mechanick J, Youdim A, Jones DB. AACE/TOS/ASMBS guidelines clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013;21(0 1):S1–27.
Mc Kinney L, Skolnik N, Chrusch A. Diagnosis and management of obesity. American Academy of Family Physicians. 2013. http://www.aafp.org/dam/AAFP/documents/patient_care/fitness/obesity-diagnosis-management.pdf.
Nguyen NT, Masoomi H, Magno CP. Trends in use of bariatric surgery 2003–2008. J Am Coll Surg. 2011;213(2):261–6.
Funk LM, Jolles SA, Greenberg CC. Primary care physician decision making regarding severe obesity and bariatric surgery: a qualitative study. Surg Obes Relat Dis. 2016;12(4):893–901.
Pi-Sunyer FX, Aronne LJ, et al. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. Bethesda: National Heart, Lung, and Blood Institute; 2000.
Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013;20(5):377–88.
Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009;33(3):289–95.
Garvey WT. New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach. Endocr Pract. 2013;19(5):864–74.
Beamish AJ, Olbers T, Kelly AS, Inge TI. Cardiovascular effects of bariatric surgery. Nat Rev Cardiol. 2016;13:730–43. https://doi.org/10.1038/nrcardio.2016.162.
Santini F, Busetto L, Cresci B, Sbraccia P. SIO management algorithm for patients with overweight or obesity: consensus statement of the Italian Society for Obesity (SIO). Eat Weight Disord. 2016;21:305–7. https://doi.org/10.1007/s40519-016-0279-3.
Dixon JB, Zimmet P, Alberti KG. International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011;28(6):628–42.
Handelsman Y, Bloomgarden ZT, Grunberger G. American Association of Clinical Endocrinologists and American College of Endocrinology – clinical practice guidelines for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2015;21(Suppl 1):1–87.
American Diabetes Association. Standards of medical care in diabetes 2017. Diabetes Care. 2017;40(Supp 1):S11.
Guo F, Moellering DR, Garvey WT. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity. 2014;22(1):110–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ackermann, M.A. (2018). Medical Management of Obesity. In: Lutfi, R., Palermo, M., Cadière, GB. (eds) Global Bariatric Surgery . Springer, Cham. https://doi.org/10.1007/978-3-319-93545-4_35
Download citation
DOI: https://doi.org/10.1007/978-3-319-93545-4_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-93544-7
Online ISBN: 978-3-319-93545-4
eBook Packages: MedicineMedicine (R0)